London & Capital Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.38M Buy
1,987
+1,594
+406% +$1.63M 0.02% 84
2026
Q1
$362K Sell
393
-1,480
-79% -$1.5M ﹤0.01% 180
2025
Q4
$2.01M Buy
+1,873
New +$1.79M 0.02% 89

Other funds holding LLY

London & Capital Asset Management's LLY Position: Q2 2026 in Review

London & Capital Asset Management increased its Eli Lilly (LLY) stake by 406% in Q2 2026, buying an estimated $1.63M and bringing the position to 1,987 shares worth $2.38M. The position accounts for 0.02% of the portfolio, ranked #84.

London & Capital Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • London & Capital Asset Management held 1,987 shares of Eli Lilly worth $2.38M as of Q2 2026.
  • London & Capital Asset Management bought 1,594 Eli Lilly shares in Q2 2026, an estimated $1.63M.
  • Eli Lilly made up 0.02% of London & Capital Asset Management's portfolio in Q2 2026, its #84 holding.
  • London & Capital Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on London & Capital Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.